Agaia s.r.o.

At Agaia s.r.o. the gynecology department focuses on reproductive and urinary physiological phenomena, specifically studying methods to prevent pregnancy. Current trials aim to demonstrate the contraceptive efficacy of a novel Levonorgestrel Vaginal Delivery System (LVDS).

• Multicentre single‑arm study evaluating LVDS over multiple cycles
• Randomised comparison of LVDS with oral desogestrel tablets
• Assessment of contraceptive performance across 9 to 13 cycles

The site in Martin, Slovakia has completed two multicentre trials with a single dedicated investigator.

Safety and tolerability are central to the research agenda, with investigations evaluating the adverse‑event profile and long‑term acceptability of LVDS compared with standard oral options such as desogestrel.

• Monitoring of adverse events during extended LVDS use
• Evaluation of user comfort and tolerability over 13 cycles
• Comparison of side‑effect incidence between vaginal and oral contraceptives

These studies aim to expand safe, non‑oral contraceptive choices for women throughout Europe.